Table 2.
Outcome | Dose rate (nSv/hr) | Cases (n) | IRa | HR (95% CI)b |
---|---|---|---|---|
All cancers | < 100 | 659 | 10.56 | 1.00 (reference) |
100 to < 150 | 982 | 11.16 | 1.06 (0.96, 1.17) | |
150 to < 200 | 112 | 12.32 | 1.17 (0.96, 1.43) | |
≥ 200 | 29 | 17.22 | 1.64 (1.13, 2.37) | |
Leukemia | < 100 | 201 | 3.22 | 1.00 (reference) |
100 to < 150 | 288 | 3.27 | 1.02 (0.85, 1.22) | |
150 to < 200 | 30 | 3.30 | 1.03 (0.70, 1.51) | |
≥ 200 | 11 | 6.53 | 2.04 (1.11, 3.74) | |
ALL | < 100 | 158 | 2.53 | 1.00 (reference) |
100 to < 150 | 225 | 2.56 | 1.01 (0.82, 1.24) | |
150 to < 200 | 24 | 2.64 | 1.05 (0.68, 1.61) | |
≥ 200 | 9 | 5.34 | 2.12 (1.09, 4.16) | |
Lymphoma | < 100 | 122 | 1.96 | 1.00 (reference) |
100 to < 150 | 186 | 2.11 | 1.08 (0.86, 1.36) | |
150 to < 200 | 17 | 1.87 | 0.96 (0.58, 1.59) | |
≥ 200 | 3 | 1.78 | 0.91 (0.29, 2.86) | |
CNS tumors | < 100 | 150 | 2.40 | 1.00 (reference) |
100 to < 150 | 239 | 2.72 | 1.13 (0.92, 1.39) | |
150 to < 200 | 26 | 2.86 | 1.19 (0.79, 1.81) | |
≥ 200 | 8 | 4.75 | 1.99 (0.98, 4.05) | |
Other malignant tumors | < 100 | 186 | 2.98 | 1.00 (reference) |
100 to < 150 | 269 | 3.06 | 1.03 (0.85, 1.24) | |
150 to < 200 | 39 | 4.29 | 1.44 (1.02, 2.04) | |
≥ 200 | 7 | 4.16 | 1.39 (0.66, 2.97) | |
Abbreviations: ALL, acute lymphoblastic leukemia; CNS, central nervous system; HR, hazard ratio; IR, incidence rate.aPer 100,000 person-years at risk. bFrom Cox proportional hazards models adjusting for sex and birth year. |